NIH – NINDS Efficacy Clinical Trials (U01)

10/01/2018 08:30

Objetivo: The purpose of this Funding Opportunity Announcement (FOA) is to encourage grant applications for investigator-initiated efficacy clinical trials to the National Institute of Neurological Disorders and Stroke (NINDS). The trials must address questions within the mission and research interests of the NINDS and may evaluate drugs, biologics, and devices, as well as surgical, behavioral and rehabilitation therapies.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.

Tags: Apoio financeiroExterior

NIH – Promoting Caregiver Health Using Self-Management (R01)

09/01/2018 09:51

Objetivo: The purpose of this initiative is to stimulate research in promoting caregiver health using self-management.  Caregiving is an important science area since the number of people living longer with chronic conditions is growing.  Informal caregivers (lay caregivers) are defined as unpaid individuals (spouses, partners, family members, friends, or neighbors) involved in assisting others with activities of daily living and/or medical tasks.  Formal caregivers are paid, delivering care in one’s home or care settings (daycare, residential care facility).  This concept focuses on informal caregivers.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.

Tags: Apoio financeiroEditalExterior

Caf – Research Fellowships 2018

09/01/2018 09:46

Objetivo: The Cooley’s Anemia Foundation invites national and international clinical and basic science investigators (postdoctoral or junior faculty) to apply for its prestigious fellowship program. Applications should be focused on the understanding or treatment of thalassemia or a complication that is related to thalassemia.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.

Tags: BolsaExterior

NIH – Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01)

09/01/2018 09:38

Objetivo: The goal of this FOA is to accelerate and improve the preclinical testing of candidate treatments and therapeutic compounds in order to move promising new drug therapies into clinical trials.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.

Tags: Apoio financeiroEditalExterior

NIH – Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01)

09/01/2018 09:35

Objetivo: This Funding Opportunity Announcement (FOA) encourages R01 grant applications that propose to develop and implement Phase III clinical trials of promising pharmacological and non-pharmacological interventions in individuals with age-related cognitive decline and across the Alzheimer’s disease (AD) spectrum from pre-symptomatic to more severe stages of disease.

Inscrições: até 05 de fevereiro de 2018

Mais informações no site.

Tags: Apoio financeiroEditalExterior